WizBiotech Drives Revenue Expansion for Pharmacies with In-Store Fingerstick POCT Testing

July 19, 2026

WizBiotech USA

Overview

WizBiotech advocates for pharmacies to expand revenue by integrating in-store fingerstick Point-of-Care Testing (POCT) services. This strategy aims to enhance patient convenience and access to testing while strengthening the pharmacy’s role as a healthcare hub. By offering rapid tests for infectious diseases, glucose levels, and cholesterol, pharmacies can secure new revenue streams and contribute to community health promotion.

In Depth

Key Findings

WizBiotech has unveiled a strategic proposition for pharmacies to expand revenue opportunities by implementing in-store fingerstick Point-of-Care Testing (POCT). This approach seeks to transform pharmacies into central hubs for community healthcare delivery by enabling patients to receive diagnostic tests more quickly and conveniently. The model aims to diversify pharmacy business models and unlock new avenues for growth beyond traditional prescription fulfillment.

Technical / Clinical Details

POCT services offered in pharmacies can cover a wide range of tests, including infectious diseases like influenza, COVID-19, and strep throat, chronic disease markers such as A1C, glucose, and cholesterol levels, and even specific drug metabolism markers. These tests utilize compact, portable analytical devices that provide results within minutes from a small fingerstick blood sample, typically a few microliters. For instance, testing kits equipped with highly sensitive biosensors can accurately detect infectious pathogens or biomarkers even at low concentrations. For patients, the primary benefit is convenient access to testing at a pharmacy, eliminating long waits at hospitals or clinics. Pharmacy staff, after minimal training, can operate these devices and provide appropriate over-the-counter product recommendations or physician referrals based on test results.

Background & Context

In recent years, the healthcare delivery paradigm has been shifting from a centralized, hospital-based model to a more decentralized, community-focused approach. Pharmacies, owing to their accessibility and established trust with local residents, are at the forefront of this transformation. The integration of POCT is a natural step for pharmacies to evolve beyond mere drug dispensing sites into essential hubs offering basic diagnostic services and preventive care. This shift is expected to alleviate the burden on the broader healthcare system and yield significant public health benefits, particularly in chronic disease management and early detection of infectious diseases.

Strategic Significance & Outlook

WizBiotech projects that this POCT integration model will be widely adopted across the pharmacy industry. In the future, more advanced biosensors and AI-based analytical capabilities are expected to be incorporated into POCT devices, further enhancing diagnostic capabilities in pharmacies. This will enable pharmacies to offer more comprehensive healthcare services, including personalized health counseling, disease management programs, and immunization services. This movement, supported by insurance providers and policymakers, will shape a future where pharmacies achieve sustainable growth and become indispensable contributors to community health. Furthermore, deeper integration with telemedicine is anticipated, positioning pharmacies as crucial touchpoints in the digital healthcare ecosystem.

Source: https://www.wizbiotech.net/news/expand-pharmacy-revenue-with-in-store-fingerstick-poct-testing

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.